Literature DB >> 9413669

Substance use among the mentally ill: a comparison of Italian and American samples.

A Fioritti1, S Ferri, L Galassi, R Warner.   

Abstract

Thirty-six patients with long-standing psychotic illness randomly selected among attenders at two community centers of Bologna were interviewed as were their therapists, in order to determine prevalence and patterns of substance use, reasons for use and effects on illness. Protocols were the same as used in previous research carried out in Boulder, Colorado. For all substances, except stimulants and over-the-counter products, prevalence rates were lower in the Bologna sample than in Boulder. Overall lifetime rates of substance use were significantly lower in the Bologna sample. Nevertheless 47.2% of the Bologna sample had a lifetime moderate to severe drug use and nearly two-thirds of the sample had a current drug use of some severity. Reasons for use equally reflected attempts to alleviate unpleasant emotional states and recreational purposes. Patients with high degrees of psychopathology had significantly lower scores on severity of drug use.

Entities:  

Mesh:

Year:  1997        PMID: 9413669     DOI: 10.1023/a:1025026619900

Source DB:  PubMed          Journal:  Community Ment Health J        ISSN: 0010-3853


  35 in total

1.  Substance use in young adults with schizophrenic disorders.

Authors:  M A Test; L S Wallisch; D J Allness; K Ripp
Journal:  Schizophr Bull       Date:  1989       Impact factor: 9.306

2.  The family history method using diagnostic criteria. Reliability and validity.

Authors:  N C Andreasen; J Endicott; R L Spitzer; G Winokur
Journal:  Arch Gen Psychiatry       Date:  1977-10

3.  Substance abuse and psychopathology. A diagnostic screening of Italian narcotic addicts.

Authors:  M Clerici; I Carta; C L Cazzullo
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  1989-07       Impact factor: 4.328

4.  A measure of severity of multi-drug use among psychiatric patients.

Authors:  M Cohen; D F Klein
Journal:  Int Pharmacopsychiatry       Date:  1971

5.  Clinical correlates of readmission in a schizophrenic cohort.

Authors:  T J Craig; S P Lin; M H el-Defrawi; A B Goodman
Journal:  Psychiatr Q       Date:  1985

6.  Multiple admissions to an urban psychiatric center: a comparative study.

Authors:  M D Carpenter; J C Mulligan; I A Bader; A E Meinzer
Journal:  Hosp Community Psychiatry       Date:  1985-12

7.  Cannabis abuse and the course of recent-onset schizophrenic disorders.

Authors:  D H Linszen; P M Dingemans; M E Lenior
Journal:  Arch Gen Psychiatry       Date:  1994-04

8.  Smoking and malignancy in schizophrenia.

Authors:  E Masterson; B O'Shea
Journal:  Br J Psychiatry       Date:  1984-10       Impact factor: 9.319

Review 9.  Genetic and clinical implications of alcoholism and affective disorder.

Authors:  M A Schuckit
Journal:  Am J Psychiatry       Date:  1986-02       Impact factor: 18.112

10.  Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia. III. A new cohort and evidence for a monoaminergic mechanism.

Authors:  D R Weinberger; K F Berman; B P Illowsky
Journal:  Arch Gen Psychiatry       Date:  1988-07
View more
  2 in total

Review 1.  Risperidone versus other antipsychotics for people with severe mental illness and co-occurring substance misuse.

Authors:  Henk S Temmingh; Taryn Williams; Nandi Siegfried; Dan J Stein
Journal:  Cochrane Database Syst Rev       Date:  2018-01-22

2.  Hospitalisation of severely mentally ill patients with and without problematic substance use before and during Assertive Community Treatment: an observational cohort study.

Authors:  Hanne Clausen; Torleif Ruud; Sigrun Odden; Jūratė Šaltytė Benth; Kristin Sverdvik Heiervang; Hanne Kilen Stuen; Helen Killaspy; Robert E Drake; Anne Landheim
Journal:  BMC Psychiatry       Date:  2016-05-04       Impact factor: 3.630

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.